INO

#4100
Inovio Pharmaceuticals, Inc.
1.19 USD
+7.21%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
1.19
1.19
Faixa anual
1.03
2.98
Mudança diária
+7.21%
Mudança mensal
-27.88%
Mudança em 6 meses
-51.23%
Mudança anual
-30.81%
Fechamento anterior
1.11
Abrir
1.19
Bid
Ask
Mínimo
1.19
High
1.19
Volume
25
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 82.22 M
  • Employee 112
  • Founded 1999
  • CEO Jacqueline Shea
  • Website www.inovio.com
  • Headquarter Delaware, United States
  • FIGI BBG000BK6YX5
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-0.96
Índice preço/fluxo de caixa
1 248.52

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

Notícias